View Clinical Trial (Medical Research Study)
PROSTATE CANCER SYMPTOM MANAGEMENT FOR LOW LITERACY MEN
| City: |
|
Houston |
| State: |
|
Texas |
| Zip Code: |
|
77030 |
| Conditions: |
|
Prostate Cancer - Psychosocial Effects of Cancer and Its Treatment |
| Purpose: |
|
RATIONALE: Gathering information about symptom management from patients with localized
prostate cancer may help doctors improve patients' quality of life.
PURPOSE: This clinical trial is studying symptom management in African-American men with
localized prostate cancer.
|
| Study Summary: |
|
OBJECTIVES:
- Develop a symptom management intervention for African-American men treated for
localized prostate cancer, with a particular emphasis on low health literacy men.
OUTLINE: Participants are interviewed by the principal investigator over the phone or meet
the principal investigator at the Veterans Administration prostate cancer clinic. If the
interview is conducted in the clinic, it is held in a private room in the clinic.
|
| Criteria: |
|
DISEASE CHARACTERISTICS:
- Biopsy-proven localized prostate cancer
- Has received treatment for prostate cancer
- Patient self-identifies as being of African-American descent
PATIENT CHARACTERISTICS:
- Able to speak and read in English
- Has an address in order to receive study materials by mail (a street address or post
office box)
- Has either a telephone in order to be interviewed OR is able to meet the principal
investigator at the Veterans Administration prostate clinic and be interviewed there
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
|
| NCT ID: |
|
NCT00767845 |
| Primary Contact: |
|
Principal Investigator
David M. Latini, PhD
Baylor College of Medicine
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Houston, Texas 77030
United States
David M. Latini, PhD
Phone: 877-794-7852
Email: canceroutcomes@bcm.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|